Product Information
LEVONOR-E ESTRAD 0.1-0.02-0.01 is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.2395 per EA under NDC 68180084813. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Oct 26, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180084813
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA091674FDA Approved
10/26/2011
TE Code
AB
On Market Since
12/2/2011
Price Statistics
The NADAC for LEVONOR-E ESTRAD 0.1-0.02-0.01 has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 86.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2395 per EA |
|---|---|
| All-time high | $1.9783 (Feb 12, 2014) |
| All-time low | $0.1337 (Jul 17, 2024) |
| 52-week high | $0.2436 |
| 52-week low | $0.1911 |
| Median price | $0.4076 |
| Average price | $0.8689 |
| Largest weekly change | +86.4% (Nov 22, 2023) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 53% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEVONOR-E ESTRAD 0.1-0.02-0.01?
The current National Average Drug Acquisition Cost (NADAC) for LEVONOR-E ESTRAD 0.1-0.02-0.01, manufactured by Lupin Pharmaceuticals Inc., is $0.2395 per EA (NDC 68180084813), effective Aug 19, 2026.
How has the price of LEVONOR-E ESTRAD 0.1-0.02-0.01 changed over time?
Over the history we have for it, the NADAC for LEVONOR-E ESTRAD 0.1-0.02-0.01 has declined 86.1%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LEVONOR-E ESTRAD 0.1-0.02-0.01?
Since Nov 28, 2013, the NADAC for LEVONOR-E ESTRAD 0.1-0.02-0.01 has ranged from a low of $0.1337 (Jul 17, 2024) to a high of $1.9783 (Feb 12, 2014), with a median of $0.4076 per EA.
Are there cheaper alternatives to LEVONOR-E ESTRAD 0.1-0.02-0.01?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, KURVELO-28 TABLET, is $0.1128 per EA — about 53% below LEVONOR-E ESTRAD 0.1-0.02-0.01.
Who manufactures LEVONOR-E ESTRAD 0.1-0.02-0.01?
LEVONOR-E ESTRAD 0.1-0.02-0.01 (NDC 68180084813) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.